iHuman Statistics

Total Valuation

iHuman has a market cap or net worth of $89.66 million. The enterprise value is -$77.34 million.

Market Cap	89.66M
Enterprise Value	-77.34M

Important Dates

The last earnings date was Thursday, February 29, 2024, before market open.

Earnings Date	Feb 29, 2024
Ex-Dividend Date	n/a

Share Statistics

iHuman has 52.74 million shares outstanding.

Shares Outstanding	52.74M
Owned by Insiders (%)	n/a
Owned by Institutions (%)	11.18%
Float	n/a

Valuation Ratios

The trailing PE ratio is 3.64 and the forward PE ratio is 58.14.

PE Ratio	3.64
Forward PE	58.14
PS Ratio	0.62
Forward PS	n/a
PB Ratio	0.68
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.00.

Current Ratio	2.82
Quick Ratio	2.60
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 20.20% and return on invested capital (ROIC) is 14.85%.

Return on Equity (ROE)	20.20%
Return on Assets (ROA)	13.10%
Return on Capital (ROIC)	14.85%
Revenue Per Employee	$186,496
Profits Per Employee	$33,137
Employee Count	770
Asset Turnover	0.74
Inventory Turnover	16.66

Taxes

In the past 12 months, iHuman has paid $2.99 million in taxes.

Income Tax	2.99M
Effective Tax Rate	10.49%

Stock Price Statistics

The stock price has decreased by -44.44% in the last 52 weeks. The beta is 0.38, so iHuman's price volatility has been lower than the market average.

Beta (1Y)	0.38
52-Week Price Change	-44.44%
50-Day Moving Average	1.94
200-Day Moving Average	2.63
Relative Strength Index (RSI)	37.30
Average Volume (30 Days)	24,374

Short Selling Information

Short Interest	1,241
Short Previous Month	1,969
Short % of Shares Out	0.00%
Short % of Float	n/a
Short Ratio (days to cover)	0.03

Income Statement

In the last 12 months, iHuman had revenue of $143.60 million and earned $25.52 million in profits. Earnings per share was $0.47.

Revenue	143.60M
Gross Profit	99.55M
Operating Income	22.07M
Pretax Income	27.96M
Net Income	25.52M
EBITDA	n/a
EBIT	27.96M
Earnings Per Share (EPS)	$0.47

Full Income Statement

Balance Sheet

The company has $167.53 million in cash and $532,774 in debt, giving a net cash position of $167.00 million or $3.17 per share.

Cash & Cash Equivalents	167.53M
Total Debt	532,774
Net Cash	167.00M
Net Cash Per Share	$3.17
Equity / Book Value	132.20M
Book Value Per Share	2.51
Working Capital	123.07M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 69.33%, with operating and profit margins of 15.37% and 17.77%.

Gross Margin	69.33%
Operating Margin	15.37%
Pretax Margin	19.47%
Profit Margin	17.77%
EBITDA Margin	n/a
EBIT Margin	19.47%
FCF Margin	n/a

Dividends & Yields

iHuman does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.06%
Shareholder Yield	1.06%
Earnings Yield	28.46%
FCF Yield	n/a

Dividend Details

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

iHuman has an Altman Z-Score of 2.57 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.57
Piotroski F-Score	6